This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover tailored wealth management advice for women to maximize their assets. Enhance your financial strategy now.
18,329 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
As the first-quarter report for Innovate lands, investors eye more than just the top line. This guide breaks down wha...
A crypto exchange’s bold political donations can reshape its regulatory path and banking access. This genre of analys...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
As investors seek clarity in a shifting media world, Newsmax’s Q1 2026 earnings offer clues about growth, profitabili...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
A major investment move puts Clearwater Analytics stock lands squarely in the spotlight. With 77% ARR growth and chat...
As Nvidia's earnings hours away approach, investors crave clarity on AI demand, profitability, and guidance. This pie...
Dorman's 2025 earnings narrative hinges on aftermarket demand, margins, and strategic bets. This guide breaks down wh...
What happened in Designer Brands (DBI) 2025 earnings, and what it means for investors in 2026. This guide breaks down...
Investors eye Xcel Brands (XELB) 2026 as it reports Q1 results. This guide explains what to look for in the transcrip...
The bwlp 2025 earnings call is a pivotal moment for BW LPG investors. This article breaks down what to expect, how to...